Skip to content
Menu
Home
about AesMed
AesMed Story
AGF39
Cytokine Therapy for Inhibition of DHT-Induced Hair Loss and Normalization of the Anagen Phase
2025-04-25
How AesMed’s AGF39™ Supports Hair Regeneration Hair loss is a common issue affecting ...
Read More
Latest Posts
Basic Causes of Alopecia & the Hair Cycle
History & KOL of AesMed: Shaping the Future of Hair Restoration
AesMed at Three Major Conferences in May 2025: Join Us in Shaping the Future of Hair Restoration
Cytokine Therapy for Inhibition of DHT-Induced Hair Loss and Normalization of the Anagen Phase
3rd Evolution in the History of Alopecia Treatment: AGF39 Cytokines Therapy for Alopecia
AesMed at KIMES 2025: Showcasing Innovation in Hair Loss Treatment
AesMed Korea at KIMES 2025 / South Korea Hair Loss
AesMed Korea – Setting the New Standard in Hair Loss Treatment
Search for:
